These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29114471)

  • 1. Beyond
    Farago AF; Azzoli CG
    Transl Lung Cancer Res; 2017 Oct; 6(5):550-559. PubMed ID: 29114471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging oncogenic fusions other than
    Suda K; Mitsudomi T
    Transl Lung Cancer Res; 2020 Dec; 9(6):2618-2628. PubMed ID: 33489822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer.
    Lira ME; Choi YL; Lim SM; Deng S; Huang D; Ozeck M; Han J; Jeong JY; Shim HS; Cho BC; Kim J; Ahn MJ; Mao M
    J Mol Diagn; 2014 Mar; 16(2):229-43. PubMed ID: 24418728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
    Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an
    Farago AF; Taylor MS; Doebele RC; Zhu VW; Kummar S; Spira AI; Boyle TA; Haura EB; Arcila ME; Benayed R; Aisner DL; Horick NK; Lennerz JK; Le LP; Iafrate AJ; Ou SI; Shaw AT; Mino-Kenudson M; Drilon A
    JCO Precis Oncol; 2018; 2018():. PubMed ID: 30215037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.
    Kohno T; Nakaoku T; Tsuta K; Tsuchihara K; Matsumoto S; Yoh K; Goto K
    Transl Lung Cancer Res; 2015 Apr; 4(2):156-64. PubMed ID: 25870798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma.
    Lamberti G; Andrini E; Sisi M; Rizzo A; Parisi C; Di Federico A; Gelsomino F; Ardizzoni A
    Crit Rev Oncol Hematol; 2020 Dec; 156():103119. PubMed ID: 33053439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New horizons for uncommon mutations in non-small cell lung cancer:
    Olmedo ME; Cervera R; Cabezon-Gutierrez L; Lage Y; Corral de la Fuente E; Gómez Rueda A; Mielgo-Rubio X; Trujillo JC; Couñago F
    World J Clin Oncol; 2022 Apr; 13(4):276-286. PubMed ID: 35582653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous analysis of
    Novaes LAC; Sussuchi da Silva L; De Marchi P; Cavagna RO; de Paula FE; Zanon MF; Evangelista AF; Albino da Silva EC; Duval da Silva V; Leal LF; Reis RM
    Transl Lung Cancer Res; 2021 Jan; 10(1):292-303. PubMed ID: 33569313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
    Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
    Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Overbeck TR; Reiffert A; Schmitz K; Rittmeyer A; Körber W; Hugo S; Schnalke J; Lukat L; Hugo T; Hinterthaner M; Reuter-Jessen K; Schildhaus HU
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC.
    Bansal P; Osman D; Gan GN; Simon GR; Boumber Y
    Front Oncol; 2016; 6():112. PubMed ID: 27200298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with
    Digumarthy SR; Mendoza DP; Lin JJ; Rooney M; Do A; Chin E; Yeap BY; Shaw AT; Gainor JF
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer.
    Tartarone A; Lapadula V; Di Micco C; Rossi G; Ottanelli C; Marini A; Giorgione R; Ferrari K; Catalano M; Voltolini L; Mini E; Roviello G
    Front Oncol; 2021; 11():632256. PubMed ID: 34094913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.
    Califano R; Abidin A; Tariq NU; Economopoulou P; Metro G; Mountzios G
    Cancer Treat Rev; 2015 May; 41(5):401-11. PubMed ID: 25842168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
    Ke L; Xu M; Jiang X; Sun X
    Med Sci Monit; 2018 Dec; 24():9364-9369. PubMed ID: 30580372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
    Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V
    Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation].
    Zhong S; Zhang H; Bai D; Gao D; Zheng J; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Sep; 44(9):639-43. PubMed ID: 26705279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of
    Reguart N; Teixidó C; Giménez-Capitán A; Paré L; Galván P; Viteri S; Rodríguez S; Peg V; Aldeguer E; Viñolas N; Remon J; Karachaliou N; Conde E; Lopez-Rios F; Nadal E; Merkelbach-Bruse S; Büttner R; Rosell R; Molina-Vila MA; Prat A
    Clin Chem; 2017 Mar; 63(3):751-760. PubMed ID: 28073897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics of
    Dugay F; Llamas-Gutierrez F; Gournay M; Medane S; Mazet F; Chiforeanu DC; Becker E; Lamy R; Léna H; Rioux-Leclercq N; Belaud-Rotureau MA; Cabillic F
    Oncotarget; 2017 Aug; 8(32):53336-53351. PubMed ID: 28881815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.